Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced that management will participate in two upcoming virtual investor conferences. Conference Details: Jefferies Virtual Healthcare Conference Date/Time: Wednesday, June 3, 2020 at 4:00 p.m. EDT Format: Fireside Chat Investor Summit Virtual Summer Summit Date/Time: Wednesday, June 10, 2020 at 3:20 p.m.
May 27, 2020
· 1 min read